(EN) Randomized Controlled Trial of Olanzapine for the Control of Chemotherapy-induced Vomiting in Children Receiving Chemotherapy for Hematopoietic Stem Cell Transplant Conditioning
1000053716
NCT03118986
 Actif en recrutement
|
CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE
|
Contrôle des symptômes |
Dr Henrique Bittencourt
Maud Frizot
514-345-4931 poste 5467
|
(EN) A 6-week, randomized, double-blind, sponsor-open study to assess the effect of repeated subcutaneous administration of pf-06946860 on appetite in participants with advanced cancer and anorexia, followed by an 18-week open-label treatment period
C3651010
NCT04803305
Actif en recrutement
|
CISSS DU BAS-SAINT-LAURENT
HOPITAL REGIONAL DE RIMOUSKI
|
Contrôle des symptômes |
Dre Marie-Claude Foley
Isabelle Gagnon
418-724-3000 poste 8029
|
(EN) Electronic 'Real-Time' Patient Self-Reporting of Immunotherapy Symptomatic Adverse Events using the SYMPTOM-IQ Tool on the uMotif Mobile Health Application (APP): A Prospective Feasibility Sub-Study of BL13 [e-PRISM]
BL13F
n.d.
Actif en recrutement
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Contrôle des symptômes |
Dr Wassim Kassouf
|
(EN) A Randomized Control Trial to Compare Doxycycline to Isotretinoin for the Treatment of Acneiform Eruptions in Cancer Patients on Tyrosine Kinase Inhibitors
2021-2635
NCT04864717
Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Contrôle des symptômes |
Dr Kevin Pehr
|
Groupe d'étude en oncologie du Québec